Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysis
Błażej Misiak, Francesco Bartoli, Giuseppe Carrà, et al.
Psychoneuroendocrinology (2021) Vol. 127, pp. 105200-105200
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Immune System Abnormalities in Schizophrenia: An Integrative View and Translational Perspectives
Evgeny A. Ermakov, Mark M. Melamud, Valentina N. Buneva, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 92
Chemokine Dysregulation and Neuroinflammation in Schizophrenia: A Systematic Review
Evgeny A. Ermakov, Irina A. Mednova, Anastasiia S. Boiko, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2215-2215
Open Access | Times Cited: 46
Associations of gut microbiota alterations with clinical, metabolic, and immune-inflammatory characteristics of chronic schizophrenia
Błażej Misiak, Edyta Pawlak, Krzysztof P. Rembacz, et al.
Journal of Psychiatric Research (2024) Vol. 171, pp. 152-160
Closed Access | Times Cited: 25
The Role of Cytokines in the Pathogenesis of Schizophrenia
Bartosz Dawidowski, Adrianna Górniak, Piotr Podwalski, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 17, pp. 3849-3849
Open Access | Times Cited: 70
Biological hypotheses, risk factors, and biomarkers of schizophrenia
Zdeněk Fišar
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110626-110626
Closed Access | Times Cited: 58
Linking Inflammation, Aberrant Glutamate-Dopamine Interaction, and Post-synaptic Changes: Translational Relevance for Schizophrenia and Antipsychotic Treatment: a Systematic Review
Andrea de Bartolomeis, Annarita Barone, Licia Vellucci, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 10, pp. 6460-6501
Open Access | Times Cited: 54
Peripheral blood inflammatory markers in patients with attention deficit/hyperactivity disorder (ADHD): A systematic review and meta-analysis
Błażej Misiak, Monika Wójta-Kempa, Jerzy Samochowiec, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 118, pp. 110581-110581
Open Access | Times Cited: 41
The association between inflammatory markers in blood and cerebrospinal fluid: a systematic review and meta-analysis
Frederieke Gigase, Emma Smith, Brett Collins, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 4, pp. 1502-1515
Closed Access | Times Cited: 34
Predictors of transition in patients with clinical high risk for psychosis: an umbrella review
Christina Andreou, S. Eickhoff, Marco Heide, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Immune Dysfunction in Schizophrenia Spectrum Disorders
Shiral S. Gangadin, Anne-Sophie D. Enthoven, Nico J.M. van Beveren, et al.
Annual Review of Clinical Psychology (2024) Vol. 20, Iss. 1, pp. 229-257
Closed Access | Times Cited: 7
SARS-CoV-2-associated cytokine storm during pregnancy as a possible risk factor for neuropsychiatric disorder development in post-pandemic infants
Cláudia P. Figueiredo, Fabrícia Lima Fontes-Dantas, Andrea T. Da Poian, et al.
Neuropharmacology (2021) Vol. 201, pp. 108841-108841
Open Access | Times Cited: 34
Schizophrenia Synaptic Pathology and Antipsychotic Treatment in the Framework of Oxidative and Mitochondrial Dysfunction: Translational Highlights for the Clinics and Treatment
Giuseppe De Simone, Benedetta Mazza, Licia Vellucci, et al.
Antioxidants (2023) Vol. 12, Iss. 4, pp. 975-975
Open Access | Times Cited: 15
The neutrophil-to-Lymphocyte ratio is associated with clinical symptoms in first-episode medication-naïve patients with schizophrenia
Xuan Wang, Xiaofang Chen, Xiaoni Guan, et al.
Schizophrenia (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Predicting the evolution from first-episode psychosis to mood or psychotic disorder: A systematic review of biological markers
Raphaël Terrisse, Florian Stéphan, Michel Walter, et al.
Journal of Affective Disorders (2025) Vol. 374, pp. 26-38
Open Access
Differential associations between cytokine and complement proteins in the clinical high risk and first episode stages of psychosis: Blood based investigation across three international studies of psychosis: NEURAPRO, STEP and OPTiMiSE
Subash Raj Susai, Rachel Davis, David Mongan, et al.
Research Square (Research Square) (2025)
Closed Access
Diagnosis and Epidemiology of Psychotic Disorders
Julie Walsh‐Messinger, Ariella Farzan Nikou, Dolores Malaspina
Oxford University Press eBooks (2025), pp. 133-146
Closed Access
Loneliness and susceptibility to social pain mediate the association between autistic traits and psychotic experiences in young non-clinical adults
Feten Fekih-Romdhane, Leila Sarra Chaibi, Amthal Alhuwailah, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Involvement of virus infections and antiviral agents in schizophrenia
Alejandro Borrego-Ruiz, Juan J. Borrego
Psychological Medicine (2025) Vol. 55
Closed Access
Relationships Between Immune‐Inflammatory Features and Social Cognitive Impairments in Patients With Schizophrenia Spectrum Disorders: A Systematic Review
Alexandre Carpentier, D. Zampetas, A. Durand, et al.
Brain and Behavior (2025) Vol. 15, Iss. 4
Open Access
Do biological alterations precede the onset of psychosis? A systematic review and meta-analysis of immune, cardiometabolic, prolactin and HPA axis alterations in clinical high-risk for psychosis
Clàudia Aymerich, Borja Pedruzo, Gonzalo Salazar de Pablo, et al.
Brain Behavior and Immunity (2025)
Open Access
Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease
Irfan Ullah, Hashir Ali Awan, Alifiya Aamir, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13032-13032
Open Access | Times Cited: 24
Serum inflammatory markers and their associations with white matter integrity of the corpus callosum in schizophrenia patients and healthy controls
Anna Michalczyk, Ernest Tyburski, Piotr Podwalski, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 116, pp. 110510-110510
Closed Access | Times Cited: 16
The Impact of Hyper-Acute Inflammatory Response on Stress Adaptation and Psychological Symptoms of COVID-19 Patients
I. Papavă, Liana Dehelean, R.S. Romoșan, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 11, pp. 6501-6501
Open Access | Times Cited: 16
The Translational Future of Stress Neurobiology and Psychosis Vulnerability: A Review of the Evidence
Alexis E. Cullen, Javier Labad, Dominic Oliver, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 3, pp. 350-377
Open Access | Times Cited: 10
Blood concentrations of anterior pituitary hormones in drug-naïve people with first-episode psychosis: A systematic review and meta-analysis
Daniele Cavaleri, Chiara Alessandra Capogrosso, Pierluca Guzzi, et al.
Psychoneuroendocrinology (2023) Vol. 158, pp. 106392-106392
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top